三元生物
(301206)
| 流通市值：34.60亿 | | | 总市值：53.74亿 |
| 流通股本：1.30亿 | | | 总股本：2.02亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 271,308,584.55 | 251,875,031.53 | 1,635,903,927.35 | 160,292,353.03 |
| 交易性金融资产 | 366,400,000 | 393,700,000 | 659,800,000 | - |
| 应收票据及应收账款 | 71,916,806.77 | 82,162,640.9 | 104,472,885.32 | 122,365,190.07 |
| 其中：应收票据 | 4,056,339.9 | 4,231,500 | 1,708,500 | 3,500,650 |
| 应收账款 | 67,860,466.87 | 77,931,140.9 | 102,764,385.32 | 118,864,540.07 |
| 预付款项 | 10,938,059.6 | 3,040,326.32 | 5,591,619.72 | 9,003,103.23 |
| 其他应收款合计 | 6,691,193.36 | 6,005,227.97 | 1,938,425.28 | 8,709,783.08 |
| 存货 | 142,746,939.12 | 191,362,372.74 | 158,835,695.87 | 142,707,159.57 |
| 一年内到期的非流动资产 | 163,624,625 | 162,330,875 | 358,995,916.67 | 2,938,873,041.66 |
| 其他流动资产 | 1,237,245,215.74 | 1,234,355,322.84 | 7,905,951.69 | 6,047,355.94 |
| 流动资产合计 | 2,270,871,424.14 | 2,324,831,797.3 | 2,933,444,421.9 | 3,387,997,986.58 |
| 非流动资产: | | | | |
| 长期股权投资 | 53,087,156.95 | 52,731,403 | 52,696,100.35 | 53,177,334.33 |
| 固定资产 | 934,535,089.61 | 951,800,398.32 | 983,509,747.22 | 998,677,280.29 |
| 在建工程 | 147,808,058.95 | 122,140,474.62 | 69,802,945.11 | 48,648,309.47 |
| 无形资产 | 45,219,295.85 | 45,492,191.48 | 46,152,820.08 | 46,425,715.71 |
| 其他非流动资产 | 1,030,408,560.8 | 1,012,549,760.71 | 665,915,594.62 | 270,325,112.74 |
| 非流动资产合计 | 2,211,058,162.16 | 2,184,714,228.13 | 1,818,077,207.38 | 1,417,253,752.54 |
| 资产总计 | 4,481,929,586.3 | 4,509,546,025.43 | 4,751,521,629.28 | 4,805,251,739.12 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 86,977,589.75 | 116,682,157.91 | 170,756,710.15 | 175,698,475.75 |
| 其中：应付票据 | 26,319,680 | 50,804,667 | 111,697,672.5 | 91,294,600 |
| 应付账款 | 60,657,909.75 | 65,877,490.91 | 59,059,037.65 | 84,403,875.75 |
| 合同负债 | 7,651,087.97 | 4,605,773.5 | 6,019,650.71 | 4,815,825.98 |
| 应付职工薪酬 | 6,438,247.75 | 5,511,721.65 | 5,293,906.37 | 7,821,271.78 |
| 应交税费 | 1,640,619.63 | 14,511,119.94 | 13,497,628.92 | 1,078,479.47 |
| 其他应付款合计 | 546,027.5 | 446,051 | 1,471,904.3 | 50,650,376.56 |
| 应付股利 | - | - | - | 50,407,500 |
| 其他流动负债 | 4,450,396.06 | 3,741,732.6 | 1,093,530.75 | 3,603,041.74 |
| 流动负债合计 | 107,703,968.66 | 145,498,556.6 | 198,133,331.2 | 243,667,471.28 |
| 非流动负债: | | | | |
| 递延收益 | 2,703,021.9 | 2,969,821.91 | 3,236,621.92 | 3,508,977.46 |
| 递延所得税负债 | 56,565,281.63 | 55,637,147.81 | 57,529,016.82 | 66,867,090.56 |
| 非流动负债合计 | 59,268,303.53 | 58,606,969.72 | 60,765,638.74 | 70,376,068.02 |
| 负债合计 | 166,972,272.19 | 204,105,526.32 | 258,898,969.94 | 314,043,539.3 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 202,325,700 | 202,325,700 | 202,325,700 | 202,325,700 |
| 资本公积 | 3,517,499,649.88 | 3,517,613,730.51 | 3,517,613,730.51 | 3,517,613,730.51 |
| 减:库存股 | 60,689,990.76 | 60,689,990.76 | 41,481,669.36 | 17,604,440.2 |
| 盈余公积 | 89,971,427.2 | 83,226,182.31 | 83,226,182.31 | 83,226,182.31 |
| 未分配利润 | 565,850,527.79 | 562,678,957.68 | 730,561,013.9 | 705,647,027.2 |
| 归属于母公司股东权益合计 | 4,314,957,314.11 | 4,305,154,579.74 | 4,492,244,957.36 | 4,491,208,199.82 |
| 少数股东权益 | - | 285,919.37 | 377,701.98 | - |
| 股东权益合计 | 4,314,957,314.11 | 4,305,440,499.11 | 4,492,622,659.34 | 4,491,208,199.82 |
| 负债和股东权益合计 | 4,481,929,586.3 | 4,509,546,025.43 | 4,751,521,629.28 | 4,805,251,739.12 |
| 公告日期 | 2025-10-27 | 2025-08-29 | 2025-04-29 | 2025-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |